We're delighted to share that Lamisil, our biggest brand and a recent addition to our portfolio, is making remarkable progress. Following a successful acquisition last year, we're already exceeding expectations in our commercial takeover plan. Even more exciting, we're expanding our partnership with Zuellig Pharma to drive Lamisil's growth across key markets in Asia. Stay tuned for more updates on this exciting journey! #smartchoices #everydayhealthcare Paul IJperen, Björkdahl Ulf, Matt Roberts, Oliver Carniol, Estel Filella, Anja Af Klint Read the full product information here: Lamisil AT 1% Cream - https://lnkd.in/dTqVEFZi, Lamisil AT 1% Gel - https://lnkd.in/d9gFA3aK, Lamisil AT 1% Spray - https://lnkd.in/d4vRF6vc, Lamisil Once - https://lnkd.in/dHzSXdtX
Great work all. 🚀
Let’s go Paul!👊 Paul IJperen
All the way up!
Well said
Great news!
DELEGADO COMERCIAL Karo Pharma
6moOjalá pronto ese en España gran producto , gran trabajo Karo